These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 22709676)

  • 1. Nonadherence to treatment protocol in published randomised controlled trials: a review.
    Dodd S; White IR; Williamson P
    Trials; 2012 Jun; 13():84. PubMed ID: 22709676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A framework for the design, conduct and interpretation of randomised controlled trials in the presence of treatment changes.
    Dodd S; White IR; Williamson P
    Trials; 2017 Oct; 18(1):498. PubMed ID: 29070048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of reporting of harms in randomised controlled trials of pharmacological interventions for rheumatoid arthritis: a systematic review.
    Hadi MA; McHugh GA; Conaghan PG
    Evid Based Med; 2017 Oct; 22(5):170-177. PubMed ID: 28866634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Reporting of Treatment Nonadherence and Its Associated Impact on Economic Evaluations Conducted Alongside Randomized Trials: A Systematic Review.
    Brilleman SL; Metcalfe C; Peters TJ; Hollingworth W
    Value Health; 2016 Jan; 19(1):99-108. PubMed ID: 26797242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Harms Reporting in Randomized Controlled Trials of Interventions Aimed at Modifying Microbiota: A Systematic Review.
    Bafeta A; Koh M; Riveros C; Ravaud P
    Ann Intern Med; 2018 Aug; 169(4):240-247. PubMed ID: 30014150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modified versus standard intention-to-treat reporting: are there differences in methodological quality, sponsorship, and findings in randomized trials? A cross-sectional study.
    Montedori A; Bonacini MI; Casazza G; Luchetta ML; Duca P; Cozzolino F; Abraha I
    Trials; 2011 Feb; 12():58. PubMed ID: 21356072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-inferiority trials: are they inferior? A systematic review of reporting in major medical journals.
    Rehal S; Morris TP; Fielding K; Carpenter JR; Phillips PP
    BMJ Open; 2016 Oct; 6(10):e012594. PubMed ID: 27855102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intention-to-treat and transparency of related practices in randomized, controlled trials of anti-infectives.
    Beckett RD; Loeser KC; Bowman KR; Towne TG
    BMC Med Res Methodol; 2016 Aug; 16(1):106. PubMed ID: 27557676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An overview of statistical methods for handling nonadherence to intervention protocol in randomized control trials: a methodological review.
    Mostazir M; Taylor RS; Henley W; Watkins E
    J Clin Epidemiol; 2019 Apr; 108():121-131. PubMed ID: 30528792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Handling missing data in RCTs; a review of the top medical journals.
    Bell ML; Fiero M; Horton NJ; Hsu CH
    BMC Med Res Methodol; 2014 Nov; 14():118. PubMed ID: 25407057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for compliance with long-term medication: a systematic review of randomised controlled trials.
    King MA; Pryce RL
    Int J Clin Pharm; 2014 Feb; 36(1):128-35. PubMed ID: 24293307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality, scope and reporting standards of randomised controlled trials in Irish Health Research: an observational study.
    Clyne B; Boland F; Murphy N; Murphy E; Moriarty F; Barry A; Wallace E; Devine T; Smith SM; Devane D; Murphy A; Fahey T
    Trials; 2020 Jun; 21(1):494. PubMed ID: 32513240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Information on adverse events in randomised clinical trials assessing drug interventions published in four medical journals with high impact factors.
    Maggi CB; Griebeler IH; Dal Pizzol Tda S
    Int J Risk Saf Med; 2014; 26(1):9-22. PubMed ID: 24796347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intention to treat (ITT) analysis as reported in orthodontic randomized controlled trials-evaluations of methodology and recommendations for the accurate use of ITT analysis and handling dropouts.
    Bondemark L; Abdulraheem S
    Eur J Orthod; 2018 Jul; 40(4):409-413. PubMed ID: 29069355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intention-to-treat analyses in behavioral medicine randomized clinical trials.
    Pagoto SL; Kozak AT; John P; Bodenlos JS; Hedeker D; Spring B; Schneider KL
    Int J Behav Med; 2009; 16(4):316-22. PubMed ID: 19319693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychological interventions for epilepsy: How good are trialists at assessing their implementation fidelity, what are the barriers, and what are journals doing to encourage it? A mixed methods study.
    Noble AJ; Marson AG; Blower SL
    Epilepsy Behav; 2019 Aug; 97():174-181. PubMed ID: 31252275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reporting number needed to treat and absolute risk reduction in randomized controlled trials.
    Nuovo J; Melnikow J; Chang D
    JAMA; 2002 Jun; 287(21):2813-4. PubMed ID: 12038920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis and reporting of adverse events in randomised controlled trials: a review.
    Phillips R; Hazell L; Sauzet O; Cornelius V
    BMJ Open; 2019 Mar; 9(2):e024537. PubMed ID: 30826796
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.